Clovis Oncology Inc (CLVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLVS | AMGN | GILD | BIIB | CELG |
| Company | Clovis Oncology Inc | Amgen Inc | Gilead Sciences Inc | Biogen Inc | Celgene Corp |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.0808 | 273.45 | 67.47 | 201.21 | 108.01 |
| High | 0.0977 | 274.35 | 67.90 | 205.36 | 108.59 |
| Low | 0.0766 | 267.24 | 65.09 | 198.11 | 107.27 |
| Last | 0.0812 | 269.38 | 65.27 | 202.46 | 108.24 |
| Change | -0.0048 | -3.63 | -1.81 | +0.47 | +0.11 |
| % Change | -5.58% | -1.33% | -2.70% | +0.23% | +0.10% |
| Volume | 24,516,400 | 1,794,000 | 15,171,900 | 1,590,300 | 191,230,496 |
| 20-Day Average Volume | 9,433,500 | 2,149,590 | 6,861,755 | 1,281,010 | 16,188,930 |
| Previous Close | 0.0860 | 273.01 | 67.08 | 201.99 | 108.13 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | No |
| Technicals | |||||
| 20-Day Moving Average | 0.2340 | 270.70 | 68.68 | 201.46 | 108.17 |
| 20-Day Raw Stochastic | 1.73% | 31.20% | 2.05% | 46.29% | 63.25% |
| 20-Day Relative Strength | 23.83% | 44.80% | 28.32% | 43.22% | 64.69% |
| Weighted Alpha | -91.19 | +9.12 | -23.73 | -34.48 | +46.30 |
| Today's Opinion | 100% Sell | 72% Sell | 100% Sell | 88% Sell | 100% Buy |
| Previous Opinion | 100% Sell | 40% Sell | 100% Sell | 100% Sell | 100% Buy |
| Last Month's Opinion | 100% Sell | 24% Buy | 88% Sell | 100% Sell | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -39.04% since 12/13/22 | +2.52% since 04/18/24 | -1.35% since 04/18/24 | +6.27% since 04/18/24 | -1.97% since 11/13/19 |
| Low | 0.0760 on 12/16/22 | 260.68 on 04/19/24 | 65.09 on 04/25/24 | 189.44 on 04/19/24 | 107.27 on 11/20/19 |
| High | 0.1439 on 12/14/22 | 274.86 on 04/24/24 | 67.90 on 04/25/24 | 205.75 on 04/24/24 | 110.53 on 11/14/19 |
| 1-Month | |||||
| %Chg | -76.74% since 11/18/22 | -4.07% since 03/25/24 | -10.07% since 03/25/24 | -6.57% since 03/25/24 | +5.14% since 10/18/19 |
| Low | 0.0760 on 12/16/22 | 260.68 on 04/19/24 | 65.09 on 04/25/24 | 189.44 on 04/19/24 | 102.40 on 10/21/19 |
| High | 0.3772 on 12/01/22 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 217.57 on 03/28/24 | 110.70 on 11/13/19 |
| 3-Month | |||||
| %Chg | -92.75% since 09/20/22 | -13.18% since 01/25/24 | -18.65% since 01/25/24 | -17.77% since 01/25/24 | +13.63% since 08/20/19 |
| Low | 0.0760 on 12/16/22 | 260.68 on 04/19/24 | 65.09 on 04/25/24 | 189.44 on 04/19/24 | 93.41 on 08/23/19 |
| High | 1.3100 on 10/04/22 | 329.72 on 02/05/24 | 80.51 on 01/26/24 | 251.99 on 01/31/24 | 110.70 on 11/13/19 |
| 6-Month | |||||
| %Chg | -93.12% since 06/17/22 | -1.02% since 10/25/23 | -16.74% since 10/25/23 | -17.94% since 10/25/23 | +14.14% since 05/20/19 |
| Low | 0.0760 on 12/16/22 | 249.70 on 10/31/23 | 65.09 on 04/25/24 | 189.44 on 04/19/24 | 89.08 on 07/23/19 |
| High | 3.2500 on 07/08/22 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 268.30 on 01/03/24 | 110.70 on 11/13/19 |
| Key Statistics | |||||
| Market Capitalization, $K | 11,770 | 144,488,960 | 81,266,176 | 29,429,788 | 77,035,920 |
| Shares Outstanding, K | 144,955 | 536,376 | 1,245,077 | 145,361 | 711,714 |
| Annual Sales | 148,760,000 | 28,190,000,000 | 27,116,000,000 | 9,835,600,000 | 15,281,000,000 |
| Annual Net Income | -264,520,000 | 6,717,000,000 | 5,665,000,000 | 1,161,100,000 | 4,046,000,000 |
| Last Quarter Sales | 30,660,000 | 8,196,000,000 | 7,114,000,000 | 2,386,300,000 | 4,520,000,000 |
| Last Quarter Net Income | -56,010,000 | 767,000,000 | 1,429,000,000 | 249,700,000 | 1,691,000,000 |
| 60-Month Beta | 0.24 | 0.58 | 0.19 | -0.02 | 1.41 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.39 on 11/09/22 | 4.71 on 02/06/24 | -1.32 on 04/25/24 | 3.67 on 04/24/24 | 2.99 on 10/31/19 |
| Latest Earnings Date | 11/09/22 | 05/02/24 | 04/25/24 | 04/24/24 | 10/31/19 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.64 | 9.98 | 13.47 | 10.99 |